Array-CGH analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genes

Genes Chromosomes and Cancer

Volumn 49, Issue 11, 2010, Pages 1046-1053

  Micci, Francesca ^a,b   Skotheim, Rolf I ^a,b   Haugom, Lisbeth ^a,b   Weimer, Jörg ^c   Eibak, Anne Mette E ^a,b   Abeler, Vera M ^a   Trope, Claes G ^a   Arnold, Norbert ^c   Lothe, Ragnhild A ^a,b   Heim, Sverre ^a,b,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ZINC FINGER PROTEIN;

ARTICLE; CARCINOGENESIS; CHROMOSOME 19; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL; SEMINOMA;

CHROMOSOMES, HUMAN, PAIR 19; FEMALE; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID HYBRIDIZATION; OVARIAN NEOPLASMS;

EID: 77957889721     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20813     Document Type: Article

References (21)

1. Atkin NB, Pickthall VJ. 1977. Chromosomes 1 in 14 ovarian cancers. Heterochromatin variants and structural changes. Hum Genet 38:25-33.
2. Banck MS, Li S, Nishio H, Wang C, Beutler AS, Walsh MJ. 2009. The ZNF217 oncogene is a candidate organizer of repressive histone modifiers. Epigenetics 4:100-106.
3. Fiegler H, Gribble SM, Burford DC, Carr P, Prigmore E, Porter KM, Clegg S, Crolla JA, Dennis NR, Jacobs P, Carter NP. 2003. Array painting: a method for the rapid analysis of aberrant chromosomes using DNA microarrays. J Med Genet 40:664-670.
4. Gribble SM, Fiegler H, Burford DC, Prigmore E, Yang F, Carr P, Ng BL, Sun T, Kamberov ES, Makarov VL, Langmore JP, Carter NP. 2004. Applications of combined DNA microarray and chromosome sorting technologies. Chromosome Res 12:35-43.
5. Huang G, Krig S, Kowbel D, Xu H, Hyun B, Volik S, Feuerstein B, Mills GB, Stokoe D, Yaswen P, Collins C. 2005. ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction. Hum Mol Genet 14:3219-3225.
6. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
7. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D. 1994. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231-243.
8. Kearny L, Hammomd DW. 2009. Molecular cytogenetic technologies. In: Rooney DE, editor. Human Cytogenetics-Malignancy and Acquired Abnormalities. Oxford: Oxford University Press, pp.129-163.
9. Micci F, Heim S. 2009. Tumors of the female genital organs. In: Heim S, Mitelman F, editors. Cancer Cytogenetics-Chromosomal and Molecular Genetic Aberrations of Tumor Cells. NJ: Wiley-Blackwell, pp.519-575.
10. Micci F, Weimer J, Haugom L, Skotheim RI, Grunewald R, Abeler VM, Silins I, Lothe RA, Trope CG, Arnold N, Heim S. 2009. Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map. Genes Chromosomes Cancer 48:184-193.
11. Mitelman F, Johansson B, Mertens F. 2010. Mitelman database of chromosome aberrations and gene fusions in cancer. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed March 1, 2010.
12. Ogawa T, Poncelet DA, Kinoshita Y, Noce T, Takeda M, Kawamoto K, Udagawa K, Lecocq PJ, Marine JC, Martial JA, Hosaka M. 1998. Enhanced expression in seminoma of human zinc finger genes located on chromosome 19. Cancer Genet Cytogenet 100:36-42.
13. Pejovic T, Heim S, Mandahl N, Elmfors B, Floderus UM, Furgyik S, Helm G, Willen H, Mitelman F. 1989. Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas. Genes Chromosomes Cancer 1:167-171.
14. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Floderus UM, Furgyik S, Helm G, Himmelmann A, Willen H. 1992. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 4:58-68.
15. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211.
16. Quinlan KG, Verger A, Yaswen P, Crossley M. 2007. Amplification of zinc finger gene 217 (ZNF217) and cancer: When good fingers go bad. Biochim Biophys Acta 1775:333-340.
17. Sambrook J, Fritsch EF, Maniatis T. 2009. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
18. Sun G, Zhou J, Yin A, Ding Y, Zhong M. 2008. Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line. Int J Oncol 32:1065-1071.
19. Veltman IM, Veltman JA, Arkesteijn G, Janssen IM, Vissers LE, de Jong PJ, van Kessel AG, Schoenmakers EF. 2003. Chromosomal breakpoint mapping by array CGH using flow-sorted chromosomes. Biotechniques 35:1066-1070.
20. Weimer J, Kiechle M, Senger G, Wiedemann U, Ovens-Raeder A, Schuierer S, Kautza M, Siebert R, Arnold N. 1999. An easy and reliable procedure of microdissection technique for the analysis of chromosomal breakpoints and marker chromosomes. Chromosome Res 7:355-362.
21. Yang L, Hamilton SR, Sood A, Kuwai T, Ellis L, Sanguino A, Lopez-Berestein G, Boyd DD. 2008. The previously unde-scribed ZKSCAN3 (ZNF306) is a novel "driver" of colorectal cancer progression. Cancer Res 68:4321-4330.